Even as a chain of events prompts the sabotage of Mary’s drug stock and leaves her seemingly without any choice but to permanently leave academic medicine, the story of her drug is not over yet. Taylor is battling terminal pancreatic cancer. Her joy turns to sorrow and then determination when she learns that Dr. Daniel Taylor, who allows her to temporarily leave her residency training to reproduce the work. After becoming a pediatrics resident, she shares her story with her beloved mentor, Dr. As death threats follow and her work becomes impossible, she is accepted at Whitehead College of Medicine despite evidence that her bosses tampered with her application process. Amid egregious sexual harassment, Mary’s materials are blatantly sabotaged.
Her work is headed for publication in a top medical journal until a drug company begins negotiations with her bosses from which she is mysteriously excluded. While working independently as a pre-med student at Cleary University, the soon-to-be physician, Mary Austin, discovers a remarkable, non-toxic drug that could offer tremendous hope to cancer patients.
0 kommentar(er)
